Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds

Skin Pharmacology and Physiology

Volumn 23, Issue 5, 2010, Pages 244-258

  Hubner N O ^a   Siebert, J ^b   Kramer, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b SCHÜLKE AND MAYR GMBH   (Germany)

Author keywords

Antimicrobial efficacy; Contraindications; Local tolerance; Mucous membrane antisepsis; Octenidine dihydrochloride; Safety; Skin antisepsis; Toxicity; Wound antisepsis

Indexed keywords

2 PHENOXYETHANOL; 2 PROPANOL; ALCOHOL; ALEXIDINE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; GENTAMICIN; GLUCOCORTICOID; HEXETIDINE; IMIPENEM; METRONIDAZOLE; OCTENIDINE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; POVIDONE IODINE; PROPANOL; PSEUDOMONIC ACID; SHAMPOO; SOAP; TRICLOSAN; PYRIDINE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ACNE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ANTISEPSIS; ANTIVIRAL ACTIVITY; BACTERIAL VAGINOSIS; BACTERICIDAL ACTIVITY; BIOFILM; CARCINOGENICITY; CLINICAL TRIAL; CYTOTOXICITY; DRUG ABSORPTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SAFETY; DRUG TOLERANCE; ECOTOXICOLOGY; GEL; GENOTOXICITY; HUMAN; LD 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; MUCOSA; NAIL INFECTION; NONHUMAN; PERIODONTAL DISEASE; PHYSICAL CHEMISTRY; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; REVIEW; SINGLE DRUG DOSE; SKIN ABSORPTION; SKIN PENETRATION; SKIN TOXICITY; TOOTH PLAQUE; TREATMENT CONTRAINDICATION; VAGINA CANDIDIASIS; VAGINITIS; WOUND; WOUND HEALING; ANIMAL; DRUG EFFECTS; MICROBIOLOGY; PROCEDURES; SKIN; TOPICAL DRUG ADMINISTRATION; WOUNDS AND INJURIES;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; HUMANS; MUCOUS MEMBRANE; PYRIDINES; SKIN; WOUNDS AND INJURIES;

EID: 77952312127     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314699     Document Type: Review

References (112)

1. Kramer A, Assadian O, Muller G, et al: Octenidine, chlorhexidine, iodine and iodophores, with introductory chapter antisepsis; in Kramer A, Assadian O (eds): Wallhaussers Praxis der Sterilisation, Desin- fektion, Antiseptik und Konservierung, ed 1, reprint. Stuttgart, Thieme, 2008.
2. Krug B, Dabek S, Muller KM, Rudolf M, Pietsch H, Ostermeyer C: Wund- und Schleimhautdesinfektionsmittel. Patent No DE 102005058978A1. 2007.
3. Dettenkofer M, Jonas D, Wiechmann C, et al: Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection 2002;30:282-285.
4. Reynolds PR, Banerjee S, Meek JH: Alcohol burns in extremely low birthweight infants: still occurring. Arch Dis Child Fetal Neonatal Ed 2005;90:F10.
5. Watkins AM, Keogh EJ: Alcohol burns in the neonate. J Paediatr Child Health 1992; 28: 306-308.
6. Kramer A, Below H, Bieber N, et al: Quantity of ethanol absorption after excessive hand disinfection using three commercially available hand rubs is minimal and below toxic levels for humans. BMC Infect Dis 2007;7:117. DOI: 10.1186/471-2334-7-117.
7. Buhrer C, Bahr S, Siebert J, et al: Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. J Hosp Infect 2002; 51:305-307.
8. Cowen J, Ellis S, McAinsh J: Absorption of chlorhexidine from the intact skin of newborn infants. Arch Dis Child 1979; 54: 379383.
9. Black J, Howes D, Rutherford T: Skin deposition and penetration of trichlorocarbanilide. Toxicology 1975;3:253-264.
10. Simon A, Christoph J, Geffers C, et al: Empfehlung zur Pravention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1,500 g. Bundesgesundheitsbl Gesundheits- forsch Gesundheitsschutz 2007; 50:12651303.
11. Fawley WN, Parnell P, Hall J, et al: Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. J Hosp Infect 2006;62: 327-332.
12. Yang JA, Park DW, Sohn JW, et al: Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resis- tant Staphylococcus aureus with low-level mupirocin resistance. J Korean Med Sci 2006:21:827-832.
13. Hurdle JG, O'Neill AJ, Mody L, et al: In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicil- lin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005;56:1166-1168.
14. Kramer A: Chlorhexidin, Octenidin; in von Bruchhausen F, Ebel S, Frahm A, Hakken- thal E (eds): Hagers Handbuch der Pharmazeutischen Praxis. Berlin, Springer, 1993.
15. Block C, Robenshtok E, Simhon A et al: Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. J Hosp Infect 2000;46:147-152.
16. Guilhermetti M, Hernandes SE, Fukushigue Y, et al: Effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from contaminated hands. Infect Control Hosp Epidemiol 2001; 22: 105-108.
17. Huang Y, Oie S, Kamiya A: Comparative effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from experimentally contaminated fingertips. Am J Infect Control 1994;22:224-227.
18. Kampf G: The value of using chlorhexidine soap in a controlled trial to eradicate MRSA in colonized patients. J Hosp Infect 2004; 58: 86.
19. Kampf G, Jarosch R, Ruden H: Limited effectiveness of chlorhexidine based hand disinfectants against methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1998;38:297.
20. Watanakunakorn C, Axelson C, Bota B, et al: Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 1995; 23:306.
21. Rengelshausen J, Nurnberger J, Philipp T, et al: Decolonization of methicillin-resistant Staphylococcus aureus by disinfection of the skin. Am J Med 2000; 108:685-686.
22. Rohr U, Mueller C, Wilhelm M, et al: Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 2003;54:305-309.
23. Sloot N, Siebert J, Hoffler U: Eradication of MRSA from carriers by means of whole- body washing with an antiseptic in combination with mupirocin nasal ointment. Zentralbl Hyg Umweltmed 1999;202:513-523.
24. Hubner NO, Wander K, Ryll S, et al: Antibiotic-free decolonisation of MRSA-positive staff. GMS Krankenhaushyg Interdiszip 2009;4:Doc04 (20091216).
25. Mayr-Kanhauser S, Kranke B, Aberer W, et al: Efficacy of octenidine dihydrochloride and 2-phenoxyethanol in the topical treatment of inflammatory acne. Acta Dermato- venerol Alp Panonica Adriat 2008;17:139-143.
26. Rigopoulos D, Rallis E, Gregoriou S, et al: Treatment of Pseudomonas nail infections with 0.1% octenidine dihydrochloride solution. Dermatology 2009;218:67-68.
27. Kramer A, Mersch-Sundermann, Gerdes H, et al: Toxikologische Bewertung fur die Han- dedesinfektion relevanter antimikrobieller Wirkstoffe; in Kampf G (ed): Hande-Hy- giene im Gesundheitswesen. Berlin, Springer, 2003, pp 106-160.
28. Tietz A, Frei R, Dangel M, et al: Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immuno- compromised patients. Infect Control Hosp Epidemiol 2005;26:703-707.
29. Enzelsberger H, Eppel W, Dorninger G, et al: Zur Effizienz von Verfahren fur die preoperative Vaginalantiseptik. Geburtshilfe Frauenheilkd 1995;55:707-710.
30. Kramer A, Fritze F, Klebingat K, et al: Ziel- setzung und Moglichkeiten der Antiseptik im Genitalbereich. Gynakologe 1999;4:182-190.
31. Rudolph P, Fritze F, Reimer K, et al: Efficacy and local tolerability of povidone iodine and octenidine hydrochloride solution for the antiseptic preparation of the orificium ure- thrae. Infection 1999;27:108-113.
32. Wewalka G, Dorninger G, Einzelsberger H, et al: Antimicrobial efficacy of procedures for preoperative vaginal antisepsis. Hyg Med 1991; 16: 335-345.
33. Wewalka G, Kurz C, Enzelsberger H: Genital antisepsis - test methodology and efficacy of povidone-iodine. Postgrad Med J 1993; 69(suppl 3):S43-S48.
34. Spitzbart H: Tolerance study on selected antiseptics using human vaginal membrane in vitro. Hyg Med 1994;19:603-607.
35. Friese K, Neumann G, Siebert J, et al: Ver- gleich zweier lokaler Antiseptika in der klinischen Anwendung bei bakteriell be- dingten Vaginalinfektionen. Geburtshilfe Frauenheilkd 2000;60:308-313.
36. Friese K, Neumann G, Siebert J: Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Arch Gyne- col Obstet 2003;268:194-197.
37. Novakov Mikic A, Budakov D: Comparison of local metronidazole and a local antiseptic in the treatment of bacterial vaginosis. Arch Gynecol Obstet 2009, E-pub ahead of print.
38. Kramer A, Hoppe H, Krull B, et al: Antiseptische Wirksamkeit und Akzeptanz von Octinisept im Vergleich zu ausgewahlten ge- wohnlichen Mundhohlenantiseptika. Zen- tralbl Hyg Umweltmed 1998;200:443-456.
39. Pitten FA, Kramer A: Antimicrobial efficacy of antiseptic mouthrinse solutions. Eur J Clin Pharmacol 1999;55:95-100.
40. Dogan AA, Cetin ES, Hussein E, et al: Microbiological evaluation of octenidine dihydrochloride mouth rinse after 5 days' use in orthodontic patients. Angle Orthod 2009;79: 766-772.
41. Barusova SA, Daurova F: Antimicrobial preparation octenisept efficacy study in treatment of inflammatory parodontal diseases. Stomatologiia 2009;88:45-49.
42. Beiswanger BB, Mallatt ME, Mau MS, et al: The clinical effects of a mouthrinse containing 0.1-percent octenidine. J Dent Res 1990; 69:454-457.
43. Ghannoum MA, Abuelteen K, Stretton RJ, et al: Effects of octenidine and pirtenidine on adhesion of Candida species to human buccal epithelial-cells in vitro. Arch Oral Biol 1990; 35: 249-253.
44. Matl FD, Zlotnyk J, Obermeier A, et al: New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids. J Biomater Sci Polym Ed 2009;20: 1439-1449.
45. Sopata M, Ciupinska M, Glowacka A, et al: Effect of octenisept antiseptic on bioburden of neoplastic ulcers in patients with advanced cancer. J Wound Care 2008; 17:24-27.
46. Kramer A, Behrens-Baumann W: Prophylactic of topical anti-infectives in ophthalmology. Ophthalmologica 1997;221:68-72.
47. Kramer A, Roth B, Muller G, et al: Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets: a double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 2004;17:141-146.
48. Vanscheidt W, Bar M, May TW, et al: Affecting the wound healing process of chronic ul- cera by an octenidine based wound antiseptic. Hyg Med 2005;5:153-158.
49. Eisenbeiss W, Kramer A, Amtsberg G, et al: Tolerability of octenidine wound gel 0.05 % vs Ringer solution in a multicenter randomised double-blinded study of phase III. In preparation.
50. Langer S, Sedigh Salakdeh M, Goertz O, et al: The impact of topical antiseptics on skin mi- crocirculation. Eur J Med Res 2004; 9: 449454.
51. Menke H, Pelzer M, Raff T, et al: Ein neues lokales Antiseptikum zur Oberflachenbe- handlung bei Schwerstverbrannten. Akt Traumatol 2001;31:211-215.
52. Hupuczi P, Papp Z: Postoperative ascites associated with intraperitoneal antiseptic lavage. Obstet Gynecol 2005;105:1267-1268.
53. Parlakgumus A, Baykal A, Aran O: An unusual cause of chemical peritonitis. Acta Chir Belg 2005; 105:322-323.
54. Guzelsagaltici N, Girgin S, Gedik E, et al: Intraperitoneal octenidine dihydro-chloride- phenoxyethanol solution to prevent peritoneal adhesion formation in a rat peritonitis model. Acta Obst Gynecol Scand 2007;86: 395-400.
55. Solberg CO: Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand J Infect Dis 2000;32:587-595.
56. Kaminski A, Kammler J, Wick M, et al: Transmission of methicillin-resistant Staphylococcus aureus among hospital staff in a German trauma centre: a problem without a current solution? J Bone Joint Surg Br 2007; 89: 642-645.
57. Wertheim HF, Melles DC, Vos MC, et al: The role of nasal carriage in Staphylococcus au- reus infections. Lancet Infect Dis 2005; 5: 751-762.
58. Wertheim HF, van Kleef M, Vos MC, et al: Nose picking and nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2006;27:863-867.
59. Siebert J, Golombiewski M, Blanckenburg R, et al: Use of octenidine dihydrochloride in semisolid preparations. Patent WO/2007/ 031520.
60. Hubner NO, Wander K, Ryll S, et al: Sanier- ung von MRSA-positiven Patienten. Med Monatsschr Pharm 2009;32:87-94.
61. Altindis M, Arikan Y, Cetinkaya Z, et al: Oc- tenidine hydrochloride in hydatid disease. J Invest Surg 2004;17:41-44.
62. Ciftci IH, Esme H, Sahin DA, et al: Effect of octenidine dihydrochloride on viability of protoscoleces in hepatic and pulmonary hy- datid diseases. J Natl Med Assoc 2007; 99: 674-677.
63. Bartoszewicz M, Rygiel A, Krzeminski M, et al: Penetration of a selected antibiotic and antiseptic into a biofilm formed on orthopedic steel implants. Orthop Traumatol Reha- bil 2007;9:310-318.
64. Bartoszewicz M, Rygiel A, Przondo-Mordar- ska A: Analysis of the effect of selected antiseptics and antibiotics on the survival of planktonic cells and biofilm cells. 7th Eur Congr Clin Microbiol and ICC, Eur Soc Clin Microbiol Infect Dis, Munich, 2007, pp 310318.
65. Harbs N, Siebert J: In vitro efficacy of octenidine and polihexanide against biofilms composed of Pseudomonas aeruginosa. GMS Krankenhaushyg Interdiszip 2007; 2:Doc45 (20071228).
66. Kalicke T, Schierholz J, Schlegel U, et al: Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res 2006;24:1622-1640.
67. Zumtobel M, Assadian O, Leonhard M, et al: The antimicrobial effect of octenidine-dihy- drochloride coated polymer tracheotomy tubes on Staphylococcus aureus and Pseudo- monas aeruginosa colonisation. BMC Microbiol 2009;9:150.
68. Raad I, Hanna HA, Chaiban G: Methods for coating and impregnating medical devices with antiseptic compositions. US Patent No 0197634. 2005.
69. A method for coating or impregnating a medical device with an antimicrobial composition. WO/2007/064835. *http://www. wipo.int/pctdb/ja/ia.jsp?ia=US2006%2F045 918&IA=US2006045918.
70. Haufe H, Thron A, Fiedler D, et al: Biocidal nanosol coatings. Surface Coatings Int B Coatings Transact 2005;88: 55-60.
71. Mahltig B, Fiedler D, Bottcher H: Antimicrobial sol-gel coatings. J Sol Gel Sci Technol 2004; 32: 219-222.
72. Harke HP: Octenidine dihydrochloride, properties of a new antimicrobial agent. Zentralbl Hyg Umweltmed 1989; 188: 188193.
73. Kramer A, Muller G: Octenidindihydro- chlorid, in Kramer A, Assadian O (eds): Wallhaussers Praxis der Sterilisation, Desin- fektion, Antiseptik und Konservierung, ed 1. Stuttgart, Thieme, 2008, pp 799-805.
74. Gilbert P, Moore LE: Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005;99:703-715.
75. Harke H, Streek M: Octenidin - ein neuer antimikrobieller Wirkstoff. Hyg Med 1989; 14: 372-374.
76. Ghannoum MA, Abuelteen K, Ellabib M, et al: Antimycotic effects of octenidine and pirtenidine. J Antimicrob Chemother 1990; 25: 237-245.
77. Ellabib M, Ghannoum MA, Whittaker PA: Effects of the pyridinamines octenidine and pirtenidine on yeast mitochondrial- function. Biochem Soc Transact 1990; 18: 342-343.
78. Harke HP, Goroncy-Bermes P: Mucous membrane antisepsis: octenidine dihydro- chloride as a new active agent. Hyg Med 1991; 16: 46-50.
79. Hubner N, Assadian O, Sciermoch K, et al: Interaktion von Antiseptika und Antibioti- ka - Grundlagen und erste Ergebnisse in vitro. GMS Krankenhaushyg Interdiszip 2007; 2:Doc59 (20071228).
80. Hubner NO, Kramer A: Interaction of octen- dine and antibiotics in vitro. In preparation.
81. Slee AM, O'Connor JR: In vitro antiplaque activity of octenidine dihydrochloride (WIN 41464-2) against preformed plaques of selected oral plaque-forming microorganisms. Antimicrob Agents Chemother 1983; 23: 379-384.
82. Harke H, Goroncy-Bermes P: Schleim- hautantiseptik - Octenidinhydrochlorid als neuer Wirkstoff. Hyg Med 1991:46-50.
83. Malinovskii NN, Reshetnikov EA, Rubash- naia IE, et al: Antiseptics on the base of oc- tenidine hydrochloride. Khirurgiia 1997;8: 8-10.
84. Bailey DM, De Grazia CG, Hoff SJ, et al: Bis- pyridinamines: a new class of topical antimicrobial agents as inhibitors of dental plaque. J Med Chem 1984;27:1457-1464.
85. Sedlock DM, Bailey DM: Microbicidal activity of octenidine hydrochloride, a new alka- nediylbis[pyridine] germicidal agent. Anti- microb Agents Chemother 1985;28:786-790.
86. Kramer A, Muller G: Microbicidal efficacy, further biological activities, tolerance and biodegradation of octenidine-dihydrochlor- id. GMS Krankenhaushyg Interdiszip 2007; 2:Doc 49.
87. Hager ROM: Hagers Handbuch der Drogen und Arzneistoffe. Berlin, Springer, 2001.
88. Hubner N, Koburger T, Braun M, et al: Direct comparison of microbiostatic and microbicidal efficacy of triclosan, PVP iodine, octeni- dine dihydrochloride, polihexanide and chlorhexidine digluconate. J Antimicrob Chemother, submitted.
89. Emilson CG, Bowen WH, Robrish SA, et al: Effect of the antibacterial agents octenidine and chlorhexidine on the plaque flora in primates. Scand J Dent Res 1981;89:384-392.
90. Shern RJ, Monell-Torrens E, Kingman A: Effect of two recently developed antiseptics on dental plaque and caries in rats. Caries Res 1985; 19: 458-465.
91. Eigener U: Untersuchungsmethode zur Pru- fung der Nachwirkung von Hautdesinfek- tionen. Zentralbl Bakteriol Mikrobiol Hyg Ser B Umwelthyg Krankenhaushyg Arbeit- shyg Prav Med 1985; 181:5.
92. Muller G, Kramer A: Interaction of octenidine and chlorhexidine with mammalian cells and the resulting microbicidal effect (remanence) of the combinations. GMS Krankenhaushyg Interdiszip 2007;2:Doc 46.
93. Ghannoum MA, Moussa NM, Whittaker P, et al: Subinhibitory concentration of octeni- dine and pirtenidine - influence on the lipid and sterol contents of Candida albicans. Chemotherapie 1992;38:46-56.
94. Wallhausser K: Praxis der Sterilisation, Desinfektion, Konservierung, ed 5. Stuttgart, Thieme, 1995.
95. Muller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008;61:1281-1287.
96. Tandjung L, Waltimo T, Hauser I, et al: Octenidine in root canal and dentine disinfection ex vivo. Int Endod J 2007;40:845-851.
97. Von Rheinbaben F, Wolff MH: Handbuch der viruswirksamen Desinfektionen. Berlin, Springer, 2002.
98. Pitten FA, Werner HP, Kramer A: A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003; 55: 108-115.
99. Shapiro S, Giertsen E, Guggenheim B: An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 2002;36:93-100.
100. Amalaradjou MA, Norris CE, Venkitana- rayanan K: Effect of octenidine hydrochlo- ride on planktonic cells and biofilms of Listeria monocytogenes. Appl Environ Mi- crobiol 2009;75:4089-4092.
101. Gradel KO, Randall L, Sayers AR, et al: Possible associations between Salmonella persistence in poultry houses and resistance to commonly used disinfectants and a putative role of mar. Vet Microbiol 2005; 107: 127-138.
102. Langsrud S, Sundheim G, Borgmann- Strahsen R: Intrinsic and acquired resistance to quaternary ammonium compounds in food-related Pseudomonas spp. J Appl Microbiol 2003;95:874-882.
103. Al-Doori Z, Goroncy-Bermes P, Gemmell CG, et al: Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 2007; 59: 1280-1281.
104. Steinhauer K, Goroncy-Bermes P: Impact of octenidine on phagocytosis of Staphylococcus aureus by neutrophils. GMS Krankenhaushyg Interdiszip 2007;2:Doc 47.
105. Weissenbacher E, Klemm A, Baumgartner I, et al: Octenisept: Studie zur Placentagan- gigkeit in einem In-vitro-Perfusionsmodell der humanen Plazenta. Int J Exp Clin Che- mother 1997;10(suppl 1):1-6.
106. Kramer A, Adrian V, Rudolph P, et al: Ex- plant test with skin and peritoneum of the neonatal rat as a predictive test of tolerance of local anti-infective agents in wounds and body cavities. Chirurg 1998;69:840-845.
107. Wagner KH, Jurss A, Zarembach B, et al: Impact of antiseptics on radical metabolism, antioxidant status and genotoxic stress in blood cells: povidone-iodine versus octenidine dihydrochloride. Toxicol In Vitro 2004;18:411-418.
108. Muller G, Kramer A: Effect of selected wound antiseptics on adult articular cartilage (bovine sesamoid bone) in the presence of Escherichia coli and Staphylococcus aureus. J Orthop Res 2005;23:127-133.
109. Hulsemann W, Habenicht R: Severe side effects after Octenisept® irrigation of penetrating wounds in children. Handchir Mi- krochir Plast Chir 2009;41:277-282.
110. Zollner H, Kramer A, Youssef P, Youssef U, Adrian V: Orientierende Untersuchungen zur biologischen Abbaubarkeit von aus- gewahlten mikrobiziden Wirkstoffen. Hyg Med 1995;20:401-407.
111. WHO: Child growth standards: weight-forage charts - boys/girls. 2008. *http://www. who.int/childgrowth/standards/chts-wfa- boys-p/en/index.html.
112. Behrends S, Siebert J, Golombiewski M, Kramer A, Muller G: Antimikrobielle Zu- bereitungen mit einem Gehalt an Oc- tenidindihydrochlorid verkapselt in Lipo- somen. Patent No DE 102005063375A1. 2007. PCT/EP2006066282. 2008